Journey Medical Corp Cash And Cash Equivalents At Carrying Value

Quick Answer

Journey Medical Corp reported Cash And Cash Equivalents At Carrying Value of $24.09 million for the year ending 2025.

  • Journey Medical Corp showed an increase of +18.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Journey Medical Corp's annual report (Form 10-K), filed with the SEC on March 26, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), Journey Medical Corp's Cash And Cash Equivalents At Carrying Value has grown by 192.1%.
  • Historical annual values: Fiscal year 2025: $24.09 million | Fiscal year 2024: $20.31 million | Fiscal year 2023: $27.44 million | Fiscal year 2022: $32.00 million | Fiscal year 2021: $49.08 million | Fiscal year 2020: $8.25 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: